Patients with COVID-19 and comorbidities who present with elevated levels of inflammatory markers and D-dimer may have an increased risk for large vessel peripheral arterial occlusion.
The use of paclitaxel-coated vs uncoated endovascular devices for the treatment of peripheral artery disease was not associated with increased mortality.
Findings based on large, national study of more than 45,000 hemodialysis patients.
Individuals living with HIV, particularly those with comorbid kidney disease, were found to be at increased risk for cardiovascular disease.
An overview of the increased risk for cardiovascular disease in patients with systemic lupus erythematosus.
A team of investigators examined the effect of a history of venous thromboembolism on recurrence of thrombosis in patients with cancer.
A 2-fold increase in mortality was seen among patients with thrombotic thrombocytopenic purpura compared with the general US population.
Results of this study contradict the currently held paradigm of stenosis-related CVD risk.
Increasing severity of white matter lesions are predictive of poor functional outcomes following acute ischemic stroke, but do not alter the effect of EVT.
Patients with thromboembolism have increased pooled odds of mortality compared to those without.
